RICHARDSON, Texas, June 16 /PRNewswire/ -- Zyvex Corporation today
announced that Hon. Jonathan C. Javitt, M.D., M.P.H. has joined its Scientific
Advisory Board. Dr. Javitt is a Senior Fellow of the Potomac Institute for
Policy Studies and an adjunct Professor of the Johns Hopkins University School
of Medicine. In May 2003, Dr. Javitt was appointed by President George W.
Bush to the President's Information Technology Advisory Committee, where he
chairs the subcommittee on health information technology.
"Jonathan Javitt has earned a world-wide reputation in the Health Care
industry," said James Von Ehr, Zyvex Founder and CEO. "Adding him to our
Scientific Advisory Board further reflects our commitment to nanotechnology
commercialization. He adds unique professional competencies and exceptional
Javitt is also Vice-Chairman of Health Directions, LLC a Bethesda-based
investment group that focuses on developing computer solutions to improve the
delivery of Health Care. He is Chief Scientific Officer of Active Health
"Dr. Javitt is regularly consulted on national policy and legal issues and
has been admitted as an expert consultant in both Federal and State
jurisdictions," said Zyvex President, Dr. Thomas A. Cellucci. "We are very
pleased that he has joined our team."
Javitt was appointed to the faculty of Johns Hopkins University in 1988
and was the first ophthalmologist to be granted a Physician Scientist Award by
the National Eye Institute of the National Institutes of Health. He joined
the faculty of Georgetown University in 1990. He is also the author of more
than 200 publications related to Health Care delivery and holds two U.S.
patents. His work has been published in the New England Journal of Medicine,
the Journal of the American Medical Association, as well as numerous other
In 1984, Javitt authored "Computers in Medicine: Applications and
Possibilities," one of the earliest books in the field. Since that time, he
has been involved in the development and commercialization of a variety of
Health Care computer applications, including electronic medical record
systems, epidemiologic tracking systems and, most recently, sentinel systems
for detecting medical errors.
Javitt has served as a member of the White House Health Reform Task Force.
He has been an expert consultant to the World Bank, the National Institutes of
Health, the Health Care Financing Administration, the Department of Veterans
Affairs, and the ministries of health of United Kingdom, Sweden, Australia,
Japan, and the Netherlands. He has been active as a consultant in
pharmacoeconomics and pharmaceutical development and has completed product
development projects for Alcon, Allergan, American Home Products, Chiron,
Lilly, Merck, Pfizer, and Pharmacia.
Javitt has been honored as a visiting professor by the University of New
South Wales (Sydney, Australia), the University of Melbourne (Melbourne,
Australia), Yamanashi Medical College (Kofu, Japan), and numerous institutions
in the United States. He is listed in "Who's Who in the World" and has been
elected to membership in the Cosmos Club (Washington, DC).
Javitt graduated in 1978 with honors in Biochemistry from Princeton
University and earned his M.D. at Cornell University Medical College. He was
awarded a Kellogg Foundation Fellowship to attend the Harvard School of Public
Health, from which he graduated with an M.P.H. in Health Policy and
Other Zyvex Scientific Advisory Board members include Dr. Alan MacDiarmid,
a 2000 Nobel Laureate in Chemistry, a Member of the National Academy of
Science, and a member of the National Academy of Engineering; Dr. Nicholas J.
Colella, Tessera Technologies; Dr. Wilson Ho, University of California
(Irvine); Dr. Joseph W. Lyding, University of Illinois; Dr. Kristofer S. J.
Pister, University of California (Berkeley); Dr. Rodney S. Ruoff, Northwestern
University; Dr. Paul S. Weiss, Pennsylvania State University; Dr. Peter Will,
University of Southern California.
Zyvex's Scientific Advisory Board contributes to Zyvex's vision of
providing flexible, automated manufacturing at ever decreasing size scales.
About the Company
Zyvex Corporation, based in Richardson, Texas, is the first molecular
nanotechnology company. Zyvex's vision is to be the leading worldwide
supplier of tools, products, and services that enable adaptable, affordable,
and molecularly precise manufacturing. Zyvex commercializes nanotechnology to
address real-world applications with high-growth potential. Zyvex carries its
scientific breakthroughs into key commercial applications in the area of
materials, tools, and structures.
Zyvex Corporation is at http://www.zyvex.com . Contact Katharine Green,
Director of Corporate Communications, at email@example.com or by phone at
972.235.7881 (ext. 220).
SOURCE Zyvex Corporation